Skip to main content

Table 1 The demographic distribution between study cohorts

From: The pyroptosis mediated biomarker pattern: an emerging diagnostic approach for Parkinson’s disease

Demographic

ncRNA

Ctl, n = 106

PD, n = 104

P value

Age,mean(SEM)

64.04 (1.198)

66.2 (1.182)

0.2000

Sex,M/F

48/58

58/46

0.1298

Disease duration (years)

NA

7.363 ± 0.8551

NA

LEDD total (mg)

NA

510.5 ± 26.86

NA

H&Y stages

NA

2.466 ± 0.08486

NA

  1. LEDD, levodopa equivalent daily dose; H&Y stages, Hoehn-Yahr stages; NA, not available; PD, Parkinson disease; Ctl, control; ncRNA, noncoding RNA